1 Introduction to Research & Analysis Reports
1.1 Medical Viscosupplementation Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Viscosupplementation Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Viscosupplementation Injection Overall Market Size
2.1 Global Medical Viscosupplementation Injection Market Size: 2022 VS 2029
2.2 Global Medical Viscosupplementation Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Viscosupplementation Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Viscosupplementation Injection Players in Global Market
3.2 Top Global Medical Viscosupplementation Injection Companies Ranked by Revenue
3.3 Global Medical Viscosupplementation Injection Revenue by Companies
3.4 Global Medical Viscosupplementation Injection Sales by Companies
3.5 Global Medical Viscosupplementation Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Viscosupplementation Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Viscosupplementation Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Viscosupplementation Injection Players in Global Market
3.8.1 List of Global Tier 1 Medical Viscosupplementation Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Viscosupplementation Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Viscosupplementation Injection Market Size Markets, 2022 & 2029
4.1.2 Single Injection
4.1.3 Three Injection
4.1.4 Five Injection
4.2 By Type – Global Medical Viscosupplementation Injection Revenue & Forecasts
4.2.1 By Type – Global Medical Viscosupplementation Injection Revenue, 2018-2023
4.2.2 By Type – Global Medical Viscosupplementation Injection Revenue, 2024-2029
4.2.3 By Type – Global Medical Viscosupplementation Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Medical Viscosupplementation Injection Sales & Forecasts
4.3.1 By Type – Global Medical Viscosupplementation Injection Sales, 2018-2023
4.3.2 By Type – Global Medical Viscosupplementation Injection Sales, 2024-2029
4.3.3 By Type – Global Medical Viscosupplementation Injection Sales Market Share, 2018-2029
4.4 By Type – Global Medical Viscosupplementation Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Viscosupplementation Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Medical Viscosupplementation Injection Revenue & Forecasts
5.2.1 By Application – Global Medical Viscosupplementation Injection Revenue, 2018-2023
5.2.2 By Application – Global Medical Viscosupplementation Injection Revenue, 2024-2029
5.2.3 By Application – Global Medical Viscosupplementation Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Medical Viscosupplementation Injection Sales & Forecasts
5.3.1 By Application – Global Medical Viscosupplementation Injection Sales, 2018-2023
5.3.2 By Application – Global Medical Viscosupplementation Injection Sales, 2024-2029
5.3.3 By Application – Global Medical Viscosupplementation Injection Sales Market Share, 2018-2029
5.4 By Application – Global Medical Viscosupplementation Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Viscosupplementation Injection Market Size, 2022 & 2029
6.2 By Region – Global Medical Viscosupplementation Injection Revenue & Forecasts
6.2.1 By Region – Global Medical Viscosupplementation Injection Revenue, 2018-2023
6.2.2 By Region – Global Medical Viscosupplementation Injection Revenue, 2024-2029
6.2.3 By Region – Global Medical Viscosupplementation Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Medical Viscosupplementation Injection Sales & Forecasts
6.3.1 By Region – Global Medical Viscosupplementation Injection Sales, 2018-2023
6.3.2 By Region – Global Medical Viscosupplementation Injection Sales, 2024-2029
6.3.3 By Region – Global Medical Viscosupplementation Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical Viscosupplementation Injection Revenue, 2018-2029
6.4.2 By Country – North America Medical Viscosupplementation Injection Sales, 2018-2029
6.4.3 US Medical Viscosupplementation Injection Market Size, 2018-2029
6.4.4 Canada Medical Viscosupplementation Injection Market Size, 2018-2029
6.4.5 Mexico Medical Viscosupplementation Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical Viscosupplementation Injection Revenue, 2018-2029
6.5.2 By Country – Europe Medical Viscosupplementation Injection Sales, 2018-2029
6.5.3 Germany Medical Viscosupplementation Injection Market Size, 2018-2029
6.5.4 France Medical Viscosupplementation Injection Market Size, 2018-2029
6.5.5 U.K. Medical Viscosupplementation Injection Market Size, 2018-2029
6.5.6 Italy Medical Viscosupplementation Injection Market Size, 2018-2029
6.5.7 Russia Medical Viscosupplementation Injection Market Size, 2018-2029
6.5.8 Nordic Countries Medical Viscosupplementation Injection Market Size, 2018-2029
6.5.9 Benelux Medical Viscosupplementation Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical Viscosupplementation Injection Revenue, 2018-2029
6.6.2 By Region – Asia Medical Viscosupplementation Injection Sales, 2018-2029
6.6.3 China Medical Viscosupplementation Injection Market Size, 2018-2029
6.6.4 Japan Medical Viscosupplementation Injection Market Size, 2018-2029
6.6.5 South Korea Medical Viscosupplementation Injection Market Size, 2018-2029
6.6.6 Southeast Asia Medical Viscosupplementation Injection Market Size, 2018-2029
6.6.7 India Medical Viscosupplementation Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical Viscosupplementation Injection Revenue, 2018-2029
6.7.2 By Country – South America Medical Viscosupplementation Injection Sales, 2018-2029
6.7.3 Brazil Medical Viscosupplementation Injection Market Size, 2018-2029
6.7.4 Argentina Medical Viscosupplementation Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Viscosupplementation Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical Viscosupplementation Injection Sales, 2018-2029
6.8.3 Turkey Medical Viscosupplementation Injection Market Size, 2018-2029
6.8.4 Israel Medical Viscosupplementation Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Viscosupplementation Injection Market Size, 2018-2029
6.8.6 UAE Medical Viscosupplementation Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Medical Viscosupplementation Injection Major Product Offerings
7.1.4 Sanofi Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Company Summary
7.2.2 Anika Therapeutics Business Overview
7.2.3 Anika Therapeutics Medical Viscosupplementation Injection Major Product Offerings
7.2.4 Anika Therapeutics Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.2.5 Anika Therapeutics Key News & Latest Developments
7.3 Seikagaku
7.3.1 Seikagaku Company Summary
7.3.2 Seikagaku Business Overview
7.3.3 Seikagaku Medical Viscosupplementation Injection Major Product Offerings
7.3.4 Seikagaku Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.3.5 Seikagaku Key News & Latest Developments
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Company Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Medical Viscosupplementation Injection Major Product Offerings
7.4.4 Zimmer Biomet Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.4.5 Zimmer Biomet Key News & Latest Developments
7.5 Bioventus
7.5.1 Bioventus Company Summary
7.5.2 Bioventus Business Overview
7.5.3 Bioventus Medical Viscosupplementation Injection Major Product Offerings
7.5.4 Bioventus Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.5.5 Bioventus Key News & Latest Developments
7.6 Ferring
7.6.1 Ferring Company Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Medical Viscosupplementation Injection Major Product Offerings
7.6.4 Ferring Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.6.5 Ferring Key News & Latest Developments
7.7 LG Chem
7.7.1 LG Chem Company Summary
7.7.2 LG Chem Business Overview
7.7.3 LG Chem Medical Viscosupplementation Injection Major Product Offerings
7.7.4 LG Chem Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.7.5 LG Chem Key News & Latest Developments
7.8 Freda
7.8.1 Freda Company Summary
7.8.2 Freda Business Overview
7.8.3 Freda Medical Viscosupplementation Injection Major Product Offerings
7.8.4 Freda Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.8.5 Freda Key News & Latest Developments
7.9 Haohai Biological
7.9.1 Haohai Biological Company Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Medical Viscosupplementation Injection Major Product Offerings
7.9.4 Haohai Biological Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.9.5 Haohai Biological Key News & Latest Developments
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Company Summary
7.10.2 Shanghai Jingfeng Business Overview
7.10.3 Shanghai Jingfeng Medical Viscosupplementation Injection Major Product Offerings
7.10.4 Shanghai Jingfeng Medical Viscosupplementation Injection Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai Jingfeng Key News & Latest Developments
8 Global Medical Viscosupplementation Injection Production Capacity, Analysis
8.1 Global Medical Viscosupplementation Injection Production Capacity, 2018-2029
8.2 Medical Viscosupplementation Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Viscosupplementation Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Viscosupplementation Injection Supply Chain Analysis
10.1 Medical Viscosupplementation Injection Industry Value Chain
10.2 Medical Viscosupplementation Injection Upstream Market
10.3 Medical Viscosupplementation Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Viscosupplementation Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の医療用関節内補充注射市場予測2023-2029：1回注射用、3回注射用、5回注射用 |
| 【英語タイトル】Medical Viscosupplementation Injection Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5255 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：73 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の医療用関節内補充注射市場規模と予測を収録しています。・世界の医療用関節内補充注射市場：売上、2018年-2023年、2024年-2029年 ・世界の医療用関節内補充注射市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の医療用関節内補充注射市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「1回注射用」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 医療用関節内補充注射のグローバル主要企業は、Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfengなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、医療用関節内補充注射のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の医療用関節内補充注射市場：タイプ別、2018年-2023年、2024年-2029年 世界の医療用関節内補充注射市場：タイプ別市場シェア、2022年 ・1回注射用、3回注射用、5回注射用 世界の医療用関節内補充注射市場：用途別、2018年-2023年、2024年-2029年 世界の医療用関節内補充注射市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の医療用関節内補充注射市場：地域・国別、2018年-2023年、2024年-2029年 世界の医療用関節内補充注射市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における医療用関節内補充注射のグローバル売上、2018年-2023年 ・主要企業における医療用関節内補充注射のグローバル売上シェア、2022年 ・主要企業における医療用関節内補充注射のグローバル販売量、2018年-2023年 ・主要企業における医療用関節内補充注射のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng ************************************************************* ・調査・分析レポートの概要 医療用関節内補充注射市場の定義 市場セグメント 世界の医療用関節内補充注射市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の医療用関節内補充注射市場規模 世界の医療用関節内補充注射市場規模：2022年 VS 2029年 世界の医療用関節内補充注射市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの医療用関節内補充注射の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の医療用関節内補充注射製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：1回注射用、3回注射用、5回注射用 医療用関節内補充注射のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 医療用関節内補充注射の用途別グローバル売上・予測 ・地域別市場分析 地域別医療用関節内補充注射市場規模 2022年と2029年 地域別医療用関節内補充注射売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng ... |
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report aims to provide a comprehensive presentation of the global market for Medical Viscosupplementation Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Viscosupplementation Injection. This report contains market size and forecasts of Medical Viscosupplementation Injection in global, including the following market information:
Global Medical Viscosupplementation Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Viscosupplementation Injection Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Medical Viscosupplementation Injection companies in 2022 (%)
The global Medical Viscosupplementation Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Single Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medical Viscosupplementation Injection include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Viscosupplementation Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Viscosupplementation Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Medical Viscosupplementation Injection Market Segment Percentages, by Type, 2022 (%)
Single Injection
Three Injection
Five Injection
Global Medical Viscosupplementation Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Medical Viscosupplementation Injection Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Medical Viscosupplementation Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Medical Viscosupplementation Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Viscosupplementation Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Viscosupplementation Injection revenues share in global market, 2022 (%)
Key companies Medical Viscosupplementation Injection sales in global market, 2018-2023 (Estimated), (Units)
Key companies Medical Viscosupplementation Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Viscosupplementation Injection, market overview.
Chapter 2: Global Medical Viscosupplementation Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Viscosupplementation Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Viscosupplementation Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Viscosupplementation Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の医療用関節内補充注射市場予測2023-2029：1回注射用、3回注射用、5回注射用] (コード：MMG23JU5255)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の医療用関節内補充注射市場予測2023-2029：1回注射用、3回注射用、5回注射用]についてメールでお問い合わせ |
